Activities that exaggerate therapeutic claims, guarantee weight-loss outcomes, or undermine the importance of lifestyle modifications such as diet and physical activity will be treated as misleading promotion
CDSCO issues advisory to prevent misleading promotion of prescription drugs for obesity